US authorities relax regulations on prescription opioids / Photo: Eric BARADAT - AFP/File
-
ECB says has tools to calm markets as French debt worries rise
-
Does White House ask AI to shape policy? Democrats want the receipts
-
IMF says engaging with Iraq on preparing new bailout program
-
ECB holds rates steady after Lagarde says to quit early
-
US economy posts strong growth, inflation stubbornly high in challenge to Trump
-
ECB chief Lagarde to step down early, triggering succession race
-
French businessman takes over 2030 Winter Olympics amid leadership turmoil
-
VW says 'no time to lose' to slash costs after 5.8 billion euro loss
-
Stock markets diverge on corporate earnings, tech jitters
-
Oil majors reap bumper profits as Mideast war drives prices
-
TotalEnergies profit hits record on high oil prices
-
Taiwan says Pakistan briefly closed airspace to Taiwanese flights
-
Afghanistan opium poppy cultivation surges despite Taliban govt ban: UN
-
Samsung logs record quarterly profits despite investor AI jitters
-
Microsoft beats expectations fueled by Azure cloud business
-
Shares in Google owner Alphabet plummet on profit miss, ad slowdown
-
Shares in Google owner Alphabet sink on profit miss, ad slowdown
-
US Fed holds interest rates steady despite 'too high' inflation
-
Pioneering US labor leader Dolores Huerta dies at 96
-
Airbus aims for record deliveries despite disappointing quarter
-
US Fed holds interest rates steady despite surging inflation
-
Real Madrid, La Liga apology over Mbappe shows power of Chinese market
-
US labor leader Dolores Huerta dead: family
-
'Cruise for life' strands passengers in Cambodia as operator goes bust
US authorities relax regulations on prescription opioids
US health officials issued new recommendations Thursday to relax restrictions for doctors prescribing opioids for pain, despite the risk of addiction.
The Centers for Disease Control (CDC) revised principles issued in 2016 in an attempt to curb the opioid overdose epidemic in the United States.
Unlike the previous document, the new guide refrains from setting thresholds in terms of dosage or prescription duration.
These had led doctors to suddenly cut or drastically reduce patients' doses. States and insurance companies were also inspired to set their own limits.
Chronic pain patients had complained that they no longer had access to the drugs that would allow them to lead a normal life, and had warned of the increased risk of suicide in their ranks.
The new recommendations, compiled in a 200-page report, seek a balance. One in five Americans suffers from chronic pain and "opioids can be essential medications for the management of pain, however, they carry considerable potential risk," the authors of the document wrote.
The guidelines are not "a replacement for clinical judgment or individualized, person-centered care" or "intended to be applied as inflexible standards of care," the report says.
But it recommends caution, warning that opioids should be considered only after other pain treatments have failed, and at each step, physicians should discuss the issue with their patients.
If they decide to use opioids, they should first prescribe the lowest effective dose and then closely monitor the effects of the treatment.
If problems arise, physicians should also avoid abruptly terminating opioid prescriptions and should ensure appropriate care for those with complications.
As a precautionary measure, the agency recommends that people using opioids over a prolonged period be offered Naloxone, an antidote that can save someone who is overdosing, said Christopher Jones, a senior CDC official, at a press briefing.
Opioid prescriptions increased fourfold between 1999 and 2010 in the United States. Although the trend has reversed since 2016, they have created addictions and driven some patients to drugs like heroin and fentanyl.
Last year, the US had a record 107,000 overdose deaths, more than 70 percent of which were from illegal synthetic opioids.
D.Avraham--CPN
